FENNEC PHARMACEUTICALS INC. — All Filings
766 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
144
15-12B
15-12B/A
20-F
20FR12B
20FR12B/A
25
3
3/A
4
4/A
424B3
424B5
424B7
6-K
8-A12B
8-K
8-K/A
ARS
AW
CERTAMX
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
EFFECT
F-3
F-3/A
FWP
NT 10-Q
POS AM
REGDEX
REGDEX/A
RW
S-1
S-1/A
S-3
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-I
SC TO-I/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-K | 10-K | 0001104659-26-036182 | Mar 27, 2026 | Dec 31, 2025 |
| 4 | — | 0001468308-26-000016 | Mar 26, 2026 | — |
| 4 | — | 0002043411-26-000002 | Mar 26, 2026 | — |
| 8-K | 8-K | 0001104659-26-033885 | Mar 24, 2026 | — |
| 8-K | 8-K | 0001104659-26-028595 | Mar 16, 2026 | — |
| S-8 | FORM S-8 | 0001104659-26-024117 | Mar 5, 2026 | — |
| 8-K | 8-K | 0001104659-26-023484 | Mar 4, 2026 | — |
| 4 | — | 0001468308-26-000014 | Mar 3, 2026 | Feb 28, 2026 |
| 4 | — | 0001468316-26-000008 | Mar 3, 2026 | Feb 28, 2026 |
| 144 | — | 0001950047-26-002037 | Mar 2, 2026 | — |
| 8-K | 8-K | 0001104659-26-018128 | Feb 20, 2026 | — |
| 4 | — | 0001926254-26-000002 | Feb 19, 2026 | Feb 18, 2026 |
| 4 | — | 0001468308-26-000012 | Feb 19, 2026 | Feb 18, 2026 |
| SCHEDULE 13G/A | — | 0001013594-26-000251 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0001622627-26-000009 | Feb 11, 2026 | — |
| 4 | — | 0001468316-26-000006 | Feb 2, 2026 | — |
| 144 | — | 0001950047-26-000825 | Feb 2, 2026 | — |
| 4 | — | 0001468316-26-000004 | Feb 2, 2026 | Jan 31, 2026 |
| 4 | — | 0001468308-26-000010 | Feb 2, 2026 | Jan 31, 2026 |
| 4 | — | 0001468308-26-000008 | Jan 23, 2026 | — |
| 4 | — | 0001468308-26-000006 | Jan 15, 2026 | — |
| SCHEDULE 13G/A | — | 0001012975-26-000043 | Jan 14, 2026 | — |
| 4 | — | 0001468308-26-000004 | Jan 7, 2026 | — |
| 4 | — | 0001468308-26-000002 | Jan 5, 2026 | Dec 31, 2025 |
| 4 | — | 0001468316-26-000002 | Jan 5, 2026 | Dec 31, 2025 |
| 144 | — | 0001950047-26-000034 | Jan 2, 2026 | — |
| 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001012975-25-000985 | Dec 29, 2025 | Dec 24, 2025 |
| 8-K | 8-K | 0001104659-25-119654 | Dec 9, 2025 | — |
| 4 | — | 0001468316-25-000016 | Dec 5, 2025 | — |
| 144 | — | 0001950047-25-009880 | Dec 5, 2025 | — |
| 4 | — | 0001468308-25-000008 | Dec 2, 2025 | Dec 1, 2025 |
| 4 | — | 0001468316-25-000014 | Dec 2, 2025 | Dec 1, 2025 |
| 8-K | FORM 8-K | 0001104659-25-117697 | Dec 2, 2025 | — |
| 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001012975-25-000806 | Nov 20, 2025 | Nov 18, 2025 |
| 8-K | FORM 8-K | 0001104659-25-113915 | Nov 19, 2025 | Nov 13, 2025 |
| S-8 | FORM S-8 | 0001104659-25-113660 | Nov 18, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-113646 | Nov 18, 2025 | Nov 17, 2025 |
| 424B5 | 424B5 | 0001104659-25-113422 | Nov 18, 2025 | — |
| 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001012975-25-000793 | Nov 17, 2025 | Nov 14, 2025 |
| 424B5 | 424B5 | 0001104659-25-112916 | Nov 17, 2025 | — |
| 8-K | FORM 8-K | 0001104659-25-112912 | Nov 17, 2025 | Nov 13, 2025 |
| 424B5 | 424B5 | 0001104659-25-111305 | Nov 13, 2025 | — |
| SCHEDULE 13G | — | 0001622627-25-000039 | Nov 13, 2025 | — |
| 10-Q | 10-Q | 0001104659-25-111260 | Nov 13, 2025 | Sep 30, 2025 |
| 4 | — | 0001468316-25-000013 | Nov 6, 2025 | Nov 5, 2025 |
| 144 | — | 0001950047-25-008495 | Nov 5, 2025 | — |
| 4 | — | 0001468316-25-000011 | Nov 3, 2025 | Oct 31, 2025 |
| 4 | — | 0001468308-25-000007 | Nov 3, 2025 | Oct 31, 2025 |
| 4 | — | 0001185945-25-000005 | Oct 14, 2025 | Oct 10, 2025 |
| 144 | — | 0001950047-25-007886 | Oct 10, 2025 | — |